Dr. Reddy's Laboratories Shares Are Trading Higher After the Company Announced It Signed a Definitive Agreement With Haleon for Purchase of Shares of Northstar Switzerland SARL to Acquire Its Global Portfolio of Consumer Healthcare Brands in the...
Dr. Reddy's Laboratories Shares Are Trading Higher After the Company Announced It Signed a Definitive Agreement With Haleon for Purchase of Shares of Northstar Switzerland SARL to Acquire Its Global Portfolio of Consumer Healthcare Brands in the...
雷迪醫藥股份有限公司股票上漲，因爲該公司宣佈與Haleon簽署了一份明確協議，以購買Northstar Switzerland SARL的股份，收購其全球消費品保健品牌組合，其中包括在印度以外的尼古丁替代療法類別。
Dr. Reddy's Laboratories Shares Are Trading Higher After the Company Announced It Signed a Definitive Agreement With Haleon for Purchase of Shares of Northstar Switzerland SARL to Acquire Its Global Portfolio of Consumer Healthcare Brands in the Nicotine Replacement Therapy Category Outside of the United States.
Dr. Reddy's Laboratories股價上漲，因公司宣佈已與Haleon簽署明確協議，購買Northstar Switzerland SARL的股份以收購其在全球範圍外的尼古丁替代療法類消費品品牌組合。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。